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Abstract
Background: Whether the habitual use of substances (tobacco, alcohol, or areca nut (seed of the Areca palm)) can affect the
age of esophageal squamous cell carcinoma (ESCC) presentation has rarely been examined.
Methods: The study subjects were those who were males and the first time to be diagnosed as ESCC (ICD-9 150) and who
visited any of three medical centers in Taiwan between 2000 and 2009. A standardized questionnaire was used to collect
substance uses and other variables.
Results: Mean age (6SD) at presentation of ESCC was 59.2 (611.3) years in a total of 668 cases. After adjusting for other
covariates, alcohol drinkers were 3.58 years younger to have ESCC than non-drinkers (p=0.002). A similar result was found
among areca chewers, who were 6.34 years younger to have ESCC than non-chewers (p,0.0001), but not among cigarette
smokers (p=0.10). When compared to the group using 0–1 substances, subjects using both cigarettes and alcohol were
nearly 3 years younger to contract ESCC. Furthermore, those who use areca plus another substance were 7–8 years younger.
Subjects using all three substances had the greatest age difference, 9.20 years younger (p,0.0001), compared to the
comparison group.
Conclusion: Our findings suggest that habitually consuming tobacco, alcohol, and areca nut can influence the age-onset of
ESCC. Since the development of ESCC is insidious and life-threatening, our observation is worthy to be reconfirmed in the
large-scale and long-term follow-up prospective cohort studies to recommend the screening strategy of this disease.
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Introduction
Esophageal cancer is the 6th leading cause of cancer death
worldwide, estimated to be responsible for 562,000 deaths in 2008
[1]. In Taiwan, the annual incidence rate of esophageal cancer in
men has increased at least 2-fold in the recent decade (from 5.7/
10
5 in 1995 to 12.1/10
5 in 2007 (Figure S1) [2,3]. Given the
insidious nature of this neoplasm, more than 50 percent of patients
have either unresectable tumors and/or metastases at presentation
[4]. The overall 5-year survival rate for esophageal cancer is less
than 15% [5]. However, with complete surgical removal of the
tumor, the 5-year survival rate exceeds 95 percent for stage 0
disease, and is 50 to 80 percent for stage I of the disease [5].
Endoscopy assisted with mucosal iodine staining or narrow-
band imaging has increased the detection rate of early esophageal
cancers confined to the mucosa [6,7,8]. Because the majority of
esophageal cancer in Taiwan is esophageal squamous cell
carcinoma (ESCC) and early ESCC can be treated by endoscopic
mucosal resection with a 5-year survival rate of 95–100%
[9,10,11,12], implementing the strategy of screening high-risk
subjects can greatly improve the survival rate of this cancer.
Alcohol and tobacco use are well-recognized risk factors of
ESCC around the world [13,14,15,16]. Chewing of areca nut,
which is the seed of the Areca palm (Areca catechu), is a prevalent
habit in Taiwan. Two most common types of areca chewing are
noted in Taiwan: raw betel fruit and lime with Piper betle
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2,800,000 people use areca is Taiwan, more men than women
(9.8% vs. 1.6%), with the life-time prevalence as high as 15% [17].
Around the world there were six hundred million people chewing
areca nut, especially in India and Southeast Asia [18]. A series of
recent studies, including ours, have shown that areca chewing is
also a risk factor for ESCC [12,19,20,21,22]. In a case-control
study of 513 ESCC and 818 gender- and age-matched controls,
those using any two of alcohol, tobacco, or areca can contract at
least a 4-fold risk of ESCC [12]. This risk increased to 41-fold for
users of all three substances. The current American Cancer
Society guidelines for cancer screening include cancers of the
breast, cervix, colorectum, endometrium, lung, prostate, and skin,
but not esophagus [23]. Two major histological types of
esophageal cancer in the worldwide are esophageal adenocarci-
noma and ESCC. Since Barrett’s esophagus is the major risk of
esophageal adenocarcinoma, screening of patients with Barrett’s
esophagus without epithelial dysplasia has been recommended to
be performed by endoscopy every 3–5 years [24]. In contrast to
esophageal adenocarcinoma, a number of risk factors for ESCC
have also been recognized, but guidelines for screening of ESCC
in high-risk groups are still lacking. In addition, the proper initial
age and interval for screening of ESCC are yet to be defined.
Thus, in this study, we analyzed the age of patients with ESCC in
Taiwanese men at initial diagnosis and the influence of alcohol
drinking, tobacco smoking and areca nut chewing on the age of
initial presentation.
Materials and Methods
Study Subjects
In Taiwan, between the years 2000 and 2009, a multicenter
cancer patient recruitment for a molecular epidemiologic
investigation was conducted in three medical centers, National
Taiwan University Hospital (NTUH) in Taipei and Kaohsiung
Medical University Hospital (KMUH) and Kaohsiung Veterans
General Hospital (KVGH) in Kaohsiung. The study subjects were
those who were the first time to be diagnosed as ESCC (ICD-9
150) and visited these three medical centers for help [12,19]. In
order for newly diagnosed ESCC cases to be both identified and
enrolled for this study as soon as the respective histopathological
materials were confirmed, a review network for quick case
recognition and verification was established at the Departments
of Chest Surgery and Gastroenterology in these medical centers
[12]. According to our previous studies [12,19], the participated
rate was 71.5% in NTUH and ,95% in both KMUH and
KVGH. Since esophageal cancer in Taiwanese women only
accounted for 10% of total and their etiologies may be different
from those in Taiwanese men, this study focused on the analysis of
men.
Clinical and pathological features were reviewed and evaluated
by independent pathologists according to the TNM staging system
of the American Joint Committee on Cancer [25]. The ethics
review boards at Kaohsing Medical University Hospital reviewed
and approved this investigation. Written consents were obtained
from all participants.
Questionnaire
A standardized questionnaire was used to collect comprehensive
information of demographic characteristics and substance use via
an in-person interview with participants within 1 week of cancer
diagnosis. The average length of interviews was approximately
30 min. The ethics review boards at the study hospitals reviewed
and approved this investigation. Alcohol drinkers, tobacco smokers
and areca chewers were defined, respectively, as subjects who had
consumed any alcoholic beverage $1 times per week, those who
had smoked $10 tobacco cigarettes per week and those who had
chewed $1 areca-nut (measured as quid) per day for at least 6
months. The age at which a substance use started, type of
substances, daily consumption amount and duration of such use,
were documented for each participant [19]. One drink of alcohol
consumption was defined as ,14 gram of alcohol [26]. In
addition, other information such as educational levels (,high
school, high school, and .high school), study hospitals (NTUH,
KMUH, and KVGH), and clinical stages (Stage I–IV) were also
collected.
Validation of Substance Uses
Previously, we used different biomarkers in different specimens
to verify information about tobacco, alcohol, and areca from
questionnaires [12,27]. To verify the smoking status reported in
the questionnaire, we measured cotinine and creatinine levels in
the one-spot urine specimens of 22 active smokers and 74 non-
smokers from one previous community study [27]. Urinary
cotinine and creatinine were measured by liquid chromatography
tandem mass spectrometry (LC/MS/MS) equipped with a triple-
quadruple mass spectrometer and TurboIonSpray
TM (API
3000
TM, Applied Biosystems, Foster City, CA, USA) and by
spectrophotometer (U-2000, Hitachi, Tokyo, Japan) with a
wavelength set at 520 mm respectively. Means and standard
deviations (SD) of urinary cotinine levels with creatinine correction
were 1.9363.74 mg/g in 22 smokers and 0.003260.0054 mg/g
in 74 non-smokers (p,0.0001) [27].
For verifying alcohol drinking, we measured serum acetalde-
hyde, a carcinogen in animals and major metabolite of ethanol, in
35 non-smoking drinkers and 19 non-smoking non-drinkers, all
healthy, by the technique of a high-performance liquid chroma-
tography (HPLC, Beckman Coulter Module 126, UK) [28,29].
Means and SDs were 1481.786699.37 ppb in 35 non-smoking
drinkers and 996.486247.22 ppb in 19 non-smoking non-drinkers
(p=0.0012). Since areca nuts in Taiwan contain a high
concentration of safrole, a carcinogen, our previous study has
analyzed safrole-DNA adducts using the P-postlabelling method in
47 tissue specimens of esophageal cancer (16 areca chewers and 31
non-areca chewers) [30]. Safrole-DNA adducts were detected in 5
(31.3%) out of 16 areca chewers and, in contrast, detected in none
of the 31 non-areca chewers (Fischer’s exact test, p=0.0028) [31].
Statistic Analysis
Means 6 SD and medians (interquartile range, IQR) of ages
were compared according to the category of demographic
variables and clinical stage. Differences of means between two
or three groups were tested using the independent t-test or
ANOVA statistics.
The main interest of this study was to investigate the
relationship of substances uses (alcohol, tobacco, and areca nut)
with age-onset of ESCC. In addition to the effect of ever-use of
these substances, we examined whether age at start and daily
average, if uses, of consuming these substance affected the age-
onset of ESCC. For the duration (years) of substance uses, we
found the high correlation between age of study subjects and years
of alcohol drinking, cigarette smoking, and areca nut chewing
(Spearman correlation co-efficiencies r=0.64, 0.66, and 0.44,
respectively, all p-values,0.0001). Thus the variables of duration
of substance uses were not examined.
Multiple linear regressions were used to explore the relationship
of age at the diagnosis of ESCC with different substance uses,
which were significant in the univariate analysis. Although the
Areca Users and Age of Diagnosed Esophageal Cancer
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of ESCC, we still placed it in the multivariate analyses. All tests
were performed by SAS 9.1 statistical software; two-sided p
value,0.05 was considered as significant.
Results
In total, 668 case patients, all male, were analyzed. The mean
age (6SD) at presentation of ESCC was 59.2 (611.3) years.
Subjects with educational level of high school were diagnosed
ESCC younger than the other two groups (Table S1). Regarding
the distribution of clinical stage, 63 (9.4%) were stage I, 169
(25.3%) were stage II, 336 (50.3%) were stage III, and 100 (15.0%)
were stage IV of ESCC. Mean ages of initial presentation were
comparable in all stage groups (p=0.65). Since the mean age of
subjects diagnosed in KMUH was approximately 4 years younger
than those in the other two hospitals, we analyzed patient number
and frequency in different clinical stages by KMUH (n=158) and
non-KMUH (n=510). We found that patient numbers (%) of
clinical stage I, II, III and IV were 7 (4.4%), 37 (23.4%), 68
(43.0%), and 46 (23.1%) in KMUH and 56 (11.0%), 132 (25.9%),
268 (52.5%), and 54 (10.6%) in non-KMUH respectively.
Although it was significantly different (x
2=35.60; d.f.=3;
p,0.0001), KMUH had less subjects with stage I and more
subjects with stage IV than non-KMUH.
Of the 668 cases, 543 (81.3%) reported habitual alcohol
drinking, 580 (86.8%) cigarette smoking, and 298 (44.6%) areca
nut chewing. All substance users, including alcohol drinkers,
cigarette smokers, and areca nut chewers, were, on average,
diagnosed with ESCC younger than non-drinkers, non-smokers,
and non-chewers (Table 1). After adjusting for educational levels,
study hospitals, clinical stages, cigarette smoking, and areca nut
chewing, we found that alcohol drinkers had ESCC 3.58 years
younger than non-drinkers (p=0.002). A similar result was found
in areca nut chewers, who had ESCC 6.34 years younger than
non-chewers (p,0.0001), but not in cigarette smokers (p=0.10)
(Table 1).
Among subjects with alcohol drinking (n=543), we found that
subjects consumed, on average, $3 drinks per day had younger
age to have ESCC than those consumed ,3 drinks per day
(p=0.02). The same significant result was not found in age at
starting drinking (,20 yrs vs. $20 yrs). In contrast, among
subjects with areca nut use (n=298), we found that subjects who
started chewing before age 20 had, on average, ESCC at a
significantly younger age than those who started at an older age
($20 years of age) (p,0.0001). Similar results were not found in
alcohol drinkers (p=0.07) or cigarette smokers (p=0.13). The
same significant result was not found in daily average of areca nut
chewing ($20 betel nuts/day vs. ,20 betel nuts/day). Both age at
start of smoking and daily average of smoking were not
significantly associated with age-onset of ESCC (Table 1).
Our previous case-controlled study of 513 ESCC case patients
and 818 gender- and age-matched controls had demonstrated that
users of any two of the three substances can contract at least a 4-
fold risk of ESCC [12]. This risk increased up to 41-fold for users
of all three substances. Thus, using the combined non- and single-
substance users as a comparison group and adjusting for
educational levels, study hospitals, and clinical stages, subjects
with the habits of both cigarette smoking and alcohol drinking
were nearly 3 years younger to have ESCC (Table 2). Users of
areca plus another substance had even younger mean ages (7,8
years younger) than the comparison group. Subjects who use all
three substances had the largest age difference, being 9.20 years
younger than the comparison group (p,0.0001). The results
remained consistent after categorized by clinical stage (early stage,
stage I and II vs. late stage, stage III and IV) (Table 3) or study
hospitals (NTUH in Taipei vs. KMUH and KVGH in Kaohsiung)
(Table S2).
Discussion
In this study we have found that, among the substances most
linked to ESCC, alcohol and areca nut are associated with earlier
development of the disease. However, similar result was not
observed with tobacco use alone. It is well established that long-
term cigarette smoking is associated with various cardiovascular
and pulmonary diseases and cancers resulting in reduced life-
expectancy in long-term smokers [32]. Since the premature death
rate is markedly higher among smokers [33], we speculate that
these competing risks may cause some smokers to die before
cancer of the esophagus was present thereby affecting results in the
mean presenting age of ESCC.
Subjects who drank, on average, alcohol beverages $3 drinks
per day were diagnosed with ESCC approximately 2.5 years
younger than those ,3 drinks per day, whereas subjects starting to
chew areca nut before age 20 were diagnosed with ESCC
approximately 4.5 years younger than those starting after age 20.
In addition, areca nut use in combination with alcohol or cigarette
or both was associated with at least 4 years earlier of the diagnosis
of ESCC, when compared to use of cigarette and alcohol only
(Table 2). Our previous epidemiological study of 513 ESCC case
patients and 818 gender- and age-matched controls found that
users of areca plus another substance (alcohol or tobacco) had a 4–
14-fold increase in the risk of ESCC [12], but none of these 513
case patients used areca only. In contrast, 5 out of 818 healthy
controls used only areca [12]. These results may suggest that areca
plays a role in promoting the carcinogenesis of the esophagus.
Indeed, in vitro studies have suggested that arecoline, one major
alkaloid of areca nut, could promote genomic instability through
arresting cells at prometaphase with large amounts of misaligned
chromosomes and accelerate keratinocyte inflammation by
regulating cytokines production such as interleukin-6 and TNF-
alpha [30,34].
The mean age at diagnosis of ESCC in the group of 0–1
substance use was 65 years, very similar to the report (67 years)
from the cancer statistical data of the US National Cancer
Institute [23]. In addition, previous observations have found more
than half of ESCC patients had advanced cancer at presentation
[4]. In our study 65.3% (436 out of the 668) of ESCC patients
were diagnosed at late stages (stages III or IV). It has been
established that the initial staging greatly affects the survival rate of
patients with ESCC [5,35]. Given relatively high prevalence of
ESCC in Taiwan and its’ tendency to present late in the disease
course, a strategy of periodic screening for high-risk populations
may be warranted.
The appropriate age to start screening for ESCC in high-risk
groups has not yet been established, although one study has
screened residents over age 35 using esophageal balloon cytology
in Anyang County of China, where the incidence of esophageal
cancer was high [36]. This study surveyed 20,049 persons and
1,018 had grade 2 dysplasia or worse, 164 of which had invasive
cancer. Since 2000, the American Cancer Society has annually
published cancer screening guidelines which include cancers of the
breast, cervix, colorectum, endometrium, lung, prostate, and the
skin [23]. The recommendations have not covered esophageal
cancer. Main reasons may be the lack of optimal non-invasive
screening tool for esophageal cancer, and the inconclusive findings
on the definition of high-risk group for esophageal cancer,
Areca Users and Age of Diagnosed Esophageal Cancer
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alcohol, and areca use account for 83.7% of the attributable
fraction of contracting ESCC [12,19,37], people in this high-risk
group are highly recommended to have their aero-digestive system
closely monitored including the oral cavity, pharynx, larynx, and
esophagus [10,12,17,37].
The appropriate interval at which high risk, cancer-free men
should repeat screening for ESCC is unclear, although a screening
Table 1. Relationship of substance uses with diagnosed age of esophageal squamous cell carcinoma.
Variables Number Mean ± SD Median (IQR) P-value b (95% CI)
a P-value
a
Overall 668 59.2611.3 59 (67, 50)
Alcohol drinking
No 125 63.9611.8 65 (55, 73) ,0.0001 - 0.002
Yes 543 58.1610.9 58 (50, 66) 23.58 (25.86, 21.30)
a
Age at starting drinking
$20 yrs 430 58.7610.8 59 (50, 66) 0.005 - 0.07
,20 yrs 113 55.9611.1 55 (48, 63) 21.39 (22.90, 0.12)
b
Daily average
,3 drinks/day 144 59.9611.2 60 (52, 68) 0.02 - 0.02
$3 drinks/day 399 57.4610.7 57 (49, 65) 22.54 (20.48, 24.61)
c
Cigarette smoking
No 88 61.4611.5 60 (53, 70) 0.05 - 0.10
Yes 580 58.8611.2 59 (50, 67) 2.20 (20.42, 4.82)
a
Age at starting smoking
$20 yrs 356 61.2610.7 62 (53, 68) ,0.0001 - 0.13
,20 yrs 224 55.0611.0 54 (47, 62) 21.08 (22.46, 0.31)
b
Daily average
,20 cigarettes/day 420 57.5610.0 57 (50, 64) 0.07 - 0.11
$20 cigarettes/day 160 59.3611.7 60 (50, 68) 21.64 (23.68, 0.40)
c
Areca chewing ,0.0001
No 370 62.3611.8 64 (54, 71) - ,0.0001
Yes 298 55.369.2 55 (48, 62) 26.34 (27.98, 24.70)
a
Age at starting chewing
$20 yrs 235 56.268.9 56 (49, 63) 0.0002 - ,0.0001
,20 yrs 63 51.569.5 51 (44, 58) 24.51 (23.23, 25.78)
b
Daily average
,20 betel nuts/day 213 55.269.5 54 (48, 61) 0.79 - 0.78
$20 betel nuts/day 85 55.568.6 56 (49, 62) 0.34 (22.03, 2.71)
c
Abbreviations: IQR: Interquartile range; CI: Confidence interval; KMUH: Kaohsiung Medical University Hospital; KVGH: Kaohsiung Veterans General Hospital; NTUH:
National Taiwan University Hospital.
aAdjusting for educational levels (.high school vs. ,high school; high school vs. ,high school), study hospitals (KMUH vs. NTUH; KVGH vs. NTUH), clinical stage, and
substance uses (tobacco, alcohol, or areca: yes vs. no).
bCompared to $20 year of age starting to smoking, drinking or chewing.
cCompared to ,3 drinks/day in alcohol drinking, ,20 cigarettes/day in cigarette smoking, or ,20 betel nuts/day in areca chewing.
doi:10.1371/journal.pone.0025347.t001
Table 2. Association between number of substance uses and diagnosed age of esophageal squamous cell carcinoma.
Alcohol Tobacco Areca n Mean ± SD Median (IQR) b (95% CI) p-value Adjusted b
a (95% CI) p-value
#1 substance use 121 65.2611.5 67 (56, 75) - - - -
++2 249 60.9611.7 63 (52, 69) 24.29 (21.97, 26.61) ,0.0001 23.45 (21.25, 25.66) 0.002
+ 2 + 11 54.568.6 57 (48, 60) 210.65 (24.06, 217.25) 0.002 28.07 (21.80, 214.33) 0.01
2 ++ 23 56.669.9 55 (48, 63) 28.59 (23.83, 213.35) ,0.0001 27.78 (23.21, 212.34) 0.001
+++ 264 55.269.2 55 (48, 61) 210.03 (27.73, 212.33) ,0.0001 29.20 (27.00, 211.39) ,0.0001
Abbreviations: SD, standard deviation; IQR, interquartile range; CI, confidence interval.
aAdjusting for education levels, study hospitals and clinical stage.
doi:10.1371/journal.pone.0025347.t002
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has been recommended using endoscopy every 3–5 years [24].
Wang and colleagues conducted an 11-year follow-up of 578
subjects from Anyang County and nearby Linxian of Henan
Province, an area recognized as having the highest incidence of
ESCC in China. Of the initially cancer-free subjects, 23 developed
early stage esophageal cancer during follow-up. The mean time of
cancer development (from entry of the study to cancer detection)
was 5.062.9 years in males and 4.763.2 years in females;
however, the interval at which these subjects received endoscopic
examination was not reported [38]. Thus, the appropriate
frequency of screening the digestive system for cancer (especially
ESCC) is yet to be determined, and further investigation is needed.
The exposure of interest in our study was measured by
questionnaires, and recall bias is likely. The accuracy of
information on substance use in this study has been verified by
different biomarkers from different specimens to reduce the
possibility of information bias. Table 3 and Table S2 shows that
the correlation between habitual substance use and the age of
ESCC diagnosis is consistent, even after being dichotomized by
clinical stage (early stage vs. late stage) or study hospital (NTUH in
Taipei vs. KMUH and KVGH in Kaohsiung), suggesting the
findings were not confounded by other covariates. The mean age
of subjects diagnosed in KMUH was approximately 4 years
younger than those in the other two hospitals; however, KMUH
had less subjects with early stage (stage I) and more subjects with
advanced stage (stage IV) than non-KMUH. These results suggest
younger people would visit the gastroenterologists for help, when
their ESCC-related symptoms were already significant. Although
educational levels may not entirely represent for socioeconomic
status, given the question about the revenue or salary in the study
family in Taiwan is a sensitive one, the data about socioeconomic
status from interviewing study patients can be likely introduced the
bias.
This is a case-control study design. Although we found that
subjects who used two to three substances, daily drank alcohol
beverages $3 drinks, or started to chew areca before 20 years of
age had the tendency of a younger age to develop ESCC, these
observations are necessary to be reconfirmed in the large-scale
prospective cohort studies to recommend the screening program of
an early ESCC in the high-risk people.
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